INAB In8Bio Inc

Price (delayed)

$0.8825

Market cap

$38.94M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.91

Enterprise value

$31.64M

Highlights
The EPS has increased by 32% YoY and by 9% QoQ
In8Bio's equity has decreased by 30% from the previous quarter but it has increased by 4.4% YoY
In8Bio's quick ratio has increased by 17% YoY but it has decreased by 14% from the previous quarter
In8Bio's debt has increased by 17% from the previous quarter and by 3.4% YoY
INAB's net income is down by 3.8% YoY and by 3.5% from the previous quarter

Key stats

What are the main financial stats of INAB
Market
Shares outstanding
44.12M
Market cap
$38.94M
Enterprise value
$31.64M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.18
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$31.04M
EBITDA
-$28.5M
Free cash flow
-$24.06M
Per share
EPS
-$0.91
Free cash flow per share
-$0.56
Book value per share
$0.4
Revenue per share
$0
TBVPS
$0.59
Balance sheet
Total assets
$25.55M
Total liabilities
$8.02M
Debt
$5.72M
Equity
$17.53M
Working capital
$11.91M
Liquidity
Debt to equity
0.33
Current ratio
4.1
Quick ratio
3.39
Net debt/EBITDA
0.26
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-107.8%
Return on equity
-151.4%
Return on invested capital
-226.3%
Return on capital employed
-143%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INAB stock price

How has the In8Bio stock price performed over time
Intraday
1.44%
1 week
2.62%
1 month
-0.84%
1 year
-47.47%
YTD
-36.05%
QTD
3.82%

Financial performance

How have In8Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$31.13M
Net income
-$31.04M
Gross margin
N/A
Net margin
N/A
INAB's operating income is down by 4.1% year-on-year and by 3.7% since the previous quarter
INAB's net income is down by 3.8% YoY and by 3.5% from the previous quarter

Growth

What is In8Bio's growth rate over time

Valuation

What is In8Bio stock price valuation
P/E
N/A
P/B
2.18
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 32% YoY and by 9% QoQ
In8Bio's equity has decreased by 30% from the previous quarter but it has increased by 4.4% YoY

Efficiency

How efficient is In8Bio business performance
The return on equity has declined by 21% year-on-year and by 2.5% since the previous quarter
The ROA has decreased by 15% YoY and by 2.7% from the previous quarter
In8Bio's ROIC has increased by 14% YoY but it has decreased by 6% from the previous quarter

Dividends

What is INAB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INAB.

Financial health

How did In8Bio financials performed over time
The total assets has declined by 24% since the previous quarter but it is up by 3.5% year-on-year
In8Bio's quick ratio has increased by 17% YoY but it has decreased by 14% from the previous quarter
In8Bio's debt is 67% less than its equity
In8Bio's debt to equity has surged by 65% QoQ
In8Bio's equity has decreased by 30% from the previous quarter but it has increased by 4.4% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.